KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Operating Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹11 Cr | ₹5.32 Cr | ₹-0.01 Cr | ₹6.02 Cr | ₹5.30 Cr |
What is the latest Operating Profit of KILITCH DRUGS (INDIA) ?
Year | Operating Profit |
---|---|
Mar2023 | ₹11 Cr |
Mar2022 | ₹5.32 Cr |
Mar2021 | ₹-0.01 Cr |
Mar2020 | ₹6.02 Cr |
Mar2019 | ₹5.30 Cr |
How is Operating Profit of KILITCH DRUGS (INDIA) Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | 97.59 | |
Mar2022 | ₹5.32 Cr | Positive | |
Mar2021 | ₹-0.01 Cr | Negative | |
Mar2020 | ₹6.02 Cr | 13.63 | |
Mar2019 | ₹5.30 Cr | - |
Compare Operating Profit of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹556.7 Cr | 2.7% | -6.3% | 73.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 2.7% |
-6.3% |
73.3% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses